January 7, 2026 — Leads & Copy — Sensus Healthcare, Inc. (Nasdaq: SRTS) has appointed Larry Biscotti to its Board of Directors, effective immediately. Biscotti’s addition brings the total number of Sensus Healthcare Board members to six, including four independent directors.
Biscotti brings over 25 years of executive leadership experience in the medical device and healthcare technology sectors. His background includes driving commercial strategy, expanding global market share, and launching advanced imaging and oncology technologies. He is currently the President of Imaging for the U.S. and Canada at GE HealthCare.
Before his role at GE HealthCare, Biscotti held positions with Elekta, Varian Medical Systems, Toshiba Medical, SMV Nuclear Medicine, and CTI Molecular Imaging.
Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, highlighted Biscotti’s skills, value, and experience. He noted Biscotti’s history of leading multibillion-dollar P&Ls, introducing cancer treatment technologies, building commercial teams, and expanding businesses through partnerships. Sardano also emphasized Biscotti’s integrity and commitment to patient outcomes.
Biscotti said he is honored to join Sensus Healthcare’s Board of Directors. He cited the company’s commitment to innovation, clinical excellence, and patient outcomes. Biscotti said that he looks forward to supporting the company’s growth and impact for patients and clinicians.
Biscotti holds an MBA from Pepperdine University and a Bachelor of Science from Cornell University. He is also an alumnus of Harvard Business School’s Program for Leadership Development.
Sensus Healthcare, Inc. develops non-invasive treatments for skin cancer and keloids, utilizing superficial radiotherapy (SRT and IG-SRT) technology. The company aims to provide healthcare providers with patient-centric treatment platforms.
For more information, please visit www.sensushealthcare.com.
Source: Sensus Healthcare